Counterfeits Enter the Supply Chain – Your Move

When defending a pharma supply chain from counterfeiters, practitioners must equip themselves with the right damage control strategies. The threat of a breach is never too far away.

• The counterfeit pharmaceutical industry is worth over $75 billion annually, according to Interpol. 
• One illicit online pharmacy, which was taken down by US authorities, managed to generate US$55 million in just two years.
• The European Commission estimated that between 2008 and 2020 EU will incur between €1.8 and €22 billion in costs for hospitalizations as a consequence of treatment using counterfeit medicines.

We are all familiar with the alarming statistics that describe the size of the falsified medicines industry. There are so many points of attack and opportunity for legitimate medicine to intertwine with fake products.

Brand owners are stretched with managing the brand in addition to trying to prevent legitimate product from being stolen, adulterated / diluted, diverted, or infiltrated at the point of product being repackaged for parallel distribution.

[Screengrab of whitepaper]

Not a matter of if, but when and where

Let’s move past the ‘how to prepare,’ ‘take these anti-counterfeiting steps,’ ‘be proactive’ mantras.

The concern for many brand protection teams is: when a breach strikes will the team be ready to contain the issue to protect patients and defend their brand?

Download this whitepaper to discover:

1. How to validate the extent of counterfeit problem
2. How to efficiently manage cases and minimize lab resources
3. Ways to reduce company liability in the event of litigation
4. The costs of implementing overt or covert security packaging features
5. Methods to shrink the risks of freezing supply chains

Download your free copy today.